A descriptive analysis of 10,000 suicide attempters in United States managed care plans, 1998-2005

Primary Psychiatry

Volumn 14, Issue 11, 2007, Pages 52-60

  Valuck, Robert J ^a   Libby, Anne M ^a   Benton, Tami D ^b,c   Evans, Dwight L ^d,e  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d Department of Psychiatry ^*  (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CHRONIC DISEASE; DEPRESSION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MENTAL DISEASE; PSYCHIATRIC DIAGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; UNITED STATES;

EID: 36349002370     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
2. Birmaher B, Ryan ND, Williamson D, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. 1996;35(11):1427-1439.
3. Birmaher B, Arbelaez C, Brent D. Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am. 2002;11(3):619-637.
4. Weissman MM, Wolk S, Wickramaratne P, et al. Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry. 1999;56(9):794-801.
5. Weissman MM, Wolk S, Goldstein RB, et al. Depressed adolescents grown up. JAMA. 1999;281(18):1707-1713.
6. Horesh N, Orbach I, Gothelf D, Efrati M, Apter A. Comparison of the suicidal behavior of adolescent inpatients with borderline personlatiy disorder and major depression. J Nerv Ment Dis. 2003;191(9):582-588.
7. Zametkin AJ, Atler MR, Yemeni T. Suicide in teenagers: assessment, management, and prevention. JAMA. 2001;286(24):3120-3125.
8. Keith CR. Adolescent suicide. JAMA. 2001;286(24):3126-3127.
9. Posner K, Oquendo M, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychaitry. 2007;164(7):1035-1043.
10. Food and Drug Administration. FDA Updates its review of antidepressant drugs in children. FDA Talk Paper T04-31. August 20, 2004. Available at: www.fda.gov/bbs/topics/ANSWERS/2004/ANS01306.html. Accessed October 8, 2007.
11. Food and Drug Administration. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications. FDA News, May 2, 2007. Available at www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html. Accessed October 8, 2007.
12. Hammad T, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332-339.
13. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder - A propensity-adjusted retrospective cohort study. CNS Drugs. 2004;18(15):1119-1132.
14. World Health Organization. ICD-9-CM: International Statistical Classification of Diseases and Health Related Problems. 9th rev, clinical modification. Geneva: World Health Organization; 1978.
15. World Health Organization. ICD-10: International Statistical Classification of Diseases and Health Related Problems. 10th rev. Geneva: World Health Organization; 1994.
16. Suicide Contagion and the Reporting of Suicide: Recommendations from a National Workshop. Centers for Disease Control and Prevention; 1994.
17. Malone DC, Billups SJ, Valuck RJ, Carter BL. Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. IMPROVE Investigators. J Clin Epidemiol. 1999;52(6):551-557.
18. Current Procedural Terminology, 4th ed. Chicago, IL: American Medical Association; 2000.
19. Kessler RC, Borges G, Walters EE. Prevalence of Risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56(7):617-626.
20. Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA. 2005;293(20):2487-2495.
21. Gibbons, RD, Brown HB, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007;164(9):1356-1363.
22. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007;164(6):884-891.
23. Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRI's. Am J Psychiatry. 2007;164(8):1198-1205.
24. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
25. Barraclough B, Bunch J, Nelson B, Sainsbury P. A hundred cases of suicide: clinical aspects. Br J Psychiatry. 1974:125(0):355-373.
26. Robins E, Murphy GE, Wilkinson RH Jr, Gassner S, Kayes J. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health Nations Health. 1959;49(7):888-899.
27. Rich CL, Fowler RC, Fogarty LA, Young D. San Diego suicide study, III: relationships between diagnoses and stressors. Arch Gen Psychiatry. 1988;45(6):589-592.
28. Isometsa E, Henriksson M, Marttunen M, et al. Mental disorders in young and middle aged men who commit suicide. BMJ. 1995;310(6991):1366-1367.
29. Beautrais AL, Joyce PR, Mulder RT, Fergusson DM, Deavoll BJ, Nightingale SK. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case control study. Am J Psychiatry. 1996;153(8):1009-1014.
30. Isacsson G, Boethius G, Bergman U. Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr Scand. 1992;85(6):444-448.
31. Isaacson G, Holmgren P, Druid H, Bergman U. The utilization of antidepressants: a key issue in the prevention of suicide: an analysis of 5,281 suicides in Sweden during the period 1992-1994. Acta Psychiatr Scand. 1997;96:94-100.
32. Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Mann JJ. Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry. 1999;156(2):190-194.
33. Isometsa E, Henriksson M, Heikkinen M, Aro H, Lonnqvist J. Suicide and the use of antidepressants. Drug treatment of depression is inadequate [letter]. BMJ. 1994;308(6933):915.
34. Evans DL, Foa EB, Gur RE, et al, eds. Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don't Know. New York, NY: Oxford University; 2005.
35. Evans DL, Charney DS, Lewis L, eds. Physician's Guide to Depression and Bipolar Disorder. New York, NY: McGraw-Hill; 2006.
36. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry. 2007;164(7):1029-1034.
37. Horvitz-Lennon M, Normand SL, Frank RG, Goldman HH. "Usual care" for major depression in the 1990s: characteristics and expert-estimated outcomes. Am J Psychiatry. 2003;160(4):720-726.